Cameco Corporation · CCJ · FY2026 Q2 · Calendar Q3 2026

Cameco holds outlook as uranium demand and Westinghouse pipeline strengthen

The call supports a constructive operating thesis: higher uranium prices, stronger nuclear policy support and Westinghouse growth provide demand support, while execution, project timing and cost risks remain material.

Reported Before market openNYSEEnergy $33.50B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.13 Consensus $0.26
EPS surprise -50.0% Reported versus consensus
Reported revenue $573.1M Consensus $579.6M
Revenue surprise -1.1% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -2.1% Event window
SPY move +0.7% Same window
Abnormal move -2.8% Stock minus SPY
Volume 1.5× Versus trailing sessions
Subsequent drift +15.8% Up to 20 sessions
CCJSPY benchmark

Ask FN2 about CCJ FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted higher uranium spot and contract prices, increased ownership of Cigar Lake, a 91-reactor AP1000 pipeline, and a conditional $17.5 billion DOE loan commitment for AP1000 long-lead items.

Guidance delta

The annual production outlook and capex plans were unchanged. Management said temporary access issues and a short Cigar Lake shutdown did not affect annual production guidance.

Key takeaways

  • Uranium spot and contract prices were described as having reached decade highs, supporting higher realized prices.
  • Operational disruptions were limited and did not change annual production guidance.
  • Cameco increased its ownership interest in the high-grade Cigar Lake mine.
  • Westinghouse's AP1000 pipeline targets 91 reactors, with DOE financing and a U.S. Department of Commerce partnership highlighted.

Management priorities

  • Complete the increase in Cigar Lake ownership.
  • Layer contracts to capture uranium-market upside while maintaining contracting discipline.
  • Support AP1000 deployment through long-lead procurement, DOE partnership and disciplined capital allocation.

Follow CCJ with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CCJ EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $0.18 Q2 '24 actual $0.10, miss Q3 '24 estimate $0.18 Q3 '24 actual $-0.01, miss Q2 '25 estimate $0.27 Q2 '25 actual $0.51, beat Q3 '25 estimate $0.14 Q3 '25 actual $0.05, miss Q4 '25 estimate $0.29 Q4 '25 actual $0.36, beat Q1 '26 estimate $0.29 Q1 '26 actual $0.34, beat Q2 '26 estimate $0.26 Q2 '26 actual $0.13, miss Q3 '26 estimate $0.23 Q3 '26 actual $-0.00, miss Q4 '26 estimate $0.50 Q1 '27 estimate $0.59 Q2 '27 estimate $0.62 Q3 '27 estimate $0.64
Show 2 more >

Analyst Consensus ?

ConsensusBuy20 ratings
Bullish1365.0%
Neutral525.0%
Bearish210.0%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$76.91Current
$30.24Low
$109.15Average
$175High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Buy BuyMaintainOct 22, 2026
Barclays Equal Weight Equal WeightMaintainOct 19, 2026
B of A Securities Buy BuyMaintainJul 9, 2026
RBC Capital Outperform OutperformMaintainJun 29, 2026
GLJ Research Buy BuyMaintainFeb 18, 2026
Goldman Sachs Buy BuyMaintainOct 29, 2025
Scotiabank Outperform OutperformMaintainAug 19, 2024
TD Securities Action List Buy Action List BuyMaintainOct 3, 2023
Canaccord Genuity Buy BuyMaintainSep 5, 2023
Raymond James Outperform OutperformMaintainAug 3, 2023
BMO Capital Outperform Market PerformUpgradeMar 31, 2022
Bank of America Underperform UnderperformMaintainOct 4, 2017
Credit Suisse Underperform NeutralDowngradeJul 18, 2017
CIBC Outperform Sector PerformUpgradeApr 7, 2015
Salman Partners Buy HoldUpgradeOct 30, 2014
Dundee Buy NeutralUpgradeOct 9, 2014
Cowen & Co. Market Perform OutperformDowngradeAug 21, 2014
Cantor Fitzgerald Hold BuyDowngradeJul 25, 2014
Cormark Securities Market Perform BuyDowngradeFeb 11, 2014
UBS Buy BuyMaintainAug 2, 2013
JP Morgan Neutral OverweightDowngradeNov 8, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $76.91. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialChristopher Souther$125$82.02 +62.5%Oct 22, 2026
BarclaysAnalyst unavailable$95$81.52 +23.5%Oct 19, 2026
JefferiesAnalyst unavailable$138$96.38 +79.4%Sep 3, 2026
Truist FinancialAnalyst unavailable$130$99.31 +69.0%Aug 12, 2026
BarclaysAnalyst unavailable$97$89.72 +26.1%Aug 4, 2026
BarclaysAnalyst unavailable$104$91.57 +35.2%Jul 15, 2026
Truist FinancialAnalyst unavailable$129$90.2 +67.7%Jul 13, 2026
BernsteinBob Brackett$135$106.96 +75.5%Jun 15, 2026
BarclaysAnalyst unavailable$108$105.33 +40.4%May 21, 2026
ScotiabankOrest Wowkodaw$175$114.46 +127.5%May 6, 2026
BernsteinBob Brackett$147$109.97 +91.1%Feb 5, 2026
Goldman SachsAnalyst unavailable$131$126.15 +70.3%Feb 4, 2026
BernsteinAnalyst unavailable$101$102.09 +31.3%Jan 7, 2026
GLJ ResearchAnalyst unavailable$99.74$86.85 +29.7%Dec 3, 2025
Goldman SachsAnalyst unavailable$109$105.95 +41.7%Oct 29, 2025
UBSAnalyst unavailable$102$77.39 +32.6%Sep 9, 2025
CLSAMax Hopkins$102$77.14 +32.6%Sep 9, 2025
BernsteinBob Brackett$70$63.83 -9.0%Jun 10, 2025
Goldman SachsNeil Mehta$55$43.32 -28.5%Apr 1, 2024
ScotiabankOrest Wowkodaw$30.24$25.07 -60.7%Nov 1, 2021
GLJ ResearchGordon Johnson$30.24$19.11 -60.7%Sep 1, 2021
Show less

Track every rating change on CCJ the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Cameco Corporation is a prominent global enterprise specializing in the production and distribution of uranium. Its operations are structured into two core divisions: Uranium and Fuel Services. The Uranium division manages the full upstream process, encompassing the exploration, extraction, and initial processing (milling) of uranium ore, as well as the procurement and sale of uranium concentrate. Conversely, the Fuel Services division focuses on the downstream transformation of uranium. This includes the refining, conversion, and fabrication of uranium concentrate into usable forms, alongside providing related conversion services. Furthermore, this segment is responsible for manufacturing specialized fuel bundles and reactor components specifically designed for CANDU reactors. Cameco provides its essential uranium products and associated fuel services to nuclear utility clients across major international markets, including the Americas, Europe, and Asia. The company was founded in 1987 and maintains its principal office in Saskatoon, Canada.

Historical context

All CCJ earnings

Energy peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CCJ recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-04T18:07:56.485867+00:00
  2. FN2 earnings calendar · 2026-09-05T01:23:14.965082+00:00
  3. Polygon adjusted daily market bars · 2026-10-31T09:30:43.036516+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T09:30:43.033432+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.